Acute Exercise Intervention in Breast Cancer Survivors
- Conditions
- Breast Carcinoma
- Interventions
- Other: RestingBehavioral: Exercise InterventionOther: Biomarker AnalysisOther: Questionnaire Administration
- Registration Number
- NCT03779867
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Brief Summary
This trial studies how a 45-minute bout of acute exercise in women with a history of breast cancer can affect factors associated with breast cancer and help doctors learn more about how exercise can help prevent breast cancer.
In an earlier part of the study, investigators looked at the effects of the same intervention in women without a history of cancer.
- Detailed Description
OUTLINE: Participants are randomized to 1 of 2 arms.
ARM I: Participants undergo a moderate-intensity acute exercise bout over 45 minutes.
ARM II: Participants rest by sitting for 45 minutes.
EXTENSION: After completion of initial study recruitment and data collection, an extension was approved in 2023.
EXTENSION OUTLINE: Participants are randomized to 1 of 2 arms.
EXTENSION ARM I: Participants exercise on a stationary bike for 45 minutes.
EXTENSION ARM II: Participants rest by sitting for 45 minutes.
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- Female
- Target Recruitment
- 112
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Arm I (acute exercise) Questionnaire Administration Participants undergo a moderate-intensity acute exercise bout over 45 minutes. Arm II (rest) Resting Participants rest by sitting for 45 minutes. Arm II (rest) Biomarker Analysis Participants rest by sitting for 45 minutes. Arm I (acute exercise) Exercise Intervention Participants undergo a moderate-intensity acute exercise bout over 45 minutes. Arm I (acute exercise) Biomarker Analysis Participants undergo a moderate-intensity acute exercise bout over 45 minutes. Arm II (rest) Questionnaire Administration Participants rest by sitting for 45 minutes.
- Primary Outcome Measures
Name Time Method Change in Plasminogen activator inhibitor type-1 (PAI-1) level Baseline up to 45 minutes Will compare changes in PAI-1 level from baseline to 45 minutes between the exercisers and controls.
Change in PAI-1 level Baseline up to 105 minutes Will compare changes in PAI-1 level from baseline to 105 minutes between the exercisers and controls.
Change in Vascular Endothelial Growth Factor (VEGF) level Baseline up to 45 minutes Will compare changes in VEGF level from baseline to 45 minutes between the exercisers and controls.
Mean change in homeostatic model assessment of insulin resistance (HOMA-IR) Baseline up to 45 minutes Will compare the average changes in HOMA-IR from baseline to 45 minutes between the exercisers and controls.
Mean change in HOMA-IR Baseline up to 105 minutes Will compare the average changes in HOMA-IR from baseline to 105 minutes between the exercisers and controls.
Change in insulin level Baseline up to 105 minutes Will compare changes in insulin level from baseline to 105 minutes between the exercisers and controls.
Change in glucose level Baseline up to 105 minutes Will compare changes in glucose level from baseline to 105 minutes between the exercisers and controls.
Change in VEGF level Baseline up to 105 minutes Will compare changes in VEGF level from baseline to 105 minutes between the exercisers and controls.
Change in Irisin level Baseline up to 105 minutes Will compare changes in Irisin level from baseline to 105 minutes between the exercisers and controls.
- Secondary Outcome Measures
Name Time Method Effects of exercise on HOMA-IR in normal-weight participants At 45 minutes Will use the generalized estimating equations (GEE) model including the potential effect modification of weight category (normal weight versus \[vs\] overweight/obese) to compare the 45-minute exercise session on HOMA-IR in normal-weight versus overweight/obese women.
Effects of exercise on HOMA-IR in overweight/obese participants At 45 minutes Will use the GEE model including the potential effect modification of weight category (normal weight versus \[vs.\] overweight/obese) to compare the 45-minute exercise session on HOMA-IR in normal-weight versus overweight/obese women.
Change in C-reactive protein (CRP) Baseline up to 105 minutes Will compare changes in CRP level from baseline to 105 minutes between the exercisers and controls.
Change in Monocyte chemotactic protein (MCP)-1 Baseline up to 105 minutes Will compare changes in MCP-1 level from baseline to 105 minutes between the exercisers and controls.
Change in Interleukin (IL)-6 Baseline up to 105 minutes Will compare changes in IL-6 level from baseline to 105 minutes between the exercisers and controls.
Trial Locations
- Locations (1)
Fred Hutch/University of Washington Cancer Consortium
🇺🇸Seattle, Washington, United States